Significance of white-coat and masked hypertension in chronic kidney disease and end-stage renal disease.

Por: José Boggia, Ricardo Silvariño, Leonella Luzardo y Oscar Noboa.   Hypertension Research (2014) 37, 882–889.

Hypertension is a frequent and modifiable cardiovascular risk factor with a cyclic relationship with chronic kidney disease (CKD). The diagnosis, treatment, monitoring and control of high blood pressure are all mandatory not only in CKD but also in end-stage renal disease (ESRD). As demonstrated by studies using population and hypertensive patients, white-coat hypertension (WCHT) and masked hypertension (MHT) carry a particular degree of risk. The advantages of ambulatory techniques in the management and prognostic stratification of patients with CKD and ESRD have also been recognized.

Association between blood pressure and disability-free survival among community-dwelling elderly patients receiving  antihypertensive treatment

Por: Osamu Iritani, Yumi Koizumi, Yuko Hamazaki, Hiroshi Yano, Takuro Morita, Taroh Himeno, Tazuo Okuno, Masashi Okuro, Kunimitsu Iwai y  Shigeto Morimoto.   Hypertension Research (2014) 37, 772–778.

A reduction of elevated blood pressure (BP) is an important treatment goal in elderly hypertensive patients. However, excessive reduction of systolic BP (SBP) and/or diastolic BP (DBP) might be harmful in such patients. We investigated whether this was the case with regard to risk of incident disability or death in community-dwelling elderly subjects.

Sex differences in response to angiotensin II receptor blocker-based therapy in elderly, high-risk, hypertensive Japanese patients: a subanalysis of the OSCAR study

Por: Kunihiko Matsui, Shokei Kim-Mitsuyama, Hisao Ogawa, Tomio Jinnouchi, Hideaki Jinnouchi y Kikuo Arakawa for the OlmeSartan Calcium Antagonists Randomized (OSCAR) Study Group.  Hypertension Research (2014) 37, 526–532.

Essential hypertension is a common comorbid condition and risk factor for cardiovascular events; in addition to lifestyle modification, drug therapy is the main treatment strategy. Although there are indications for specific classes of antihypertensive drugs for particular patients, such as diuretics for hypertensive African Americans,1 there is no uniform agreement on the type of drug(s) that should be used when physicians choose an antihypertensive drug for newly diagnosed patients without specific indications for those drugs.  Recently, many evidence-based clinical practice guidelines from various clinical fields have been published to improve the quality of patient care.

¿La toma convencional de presión arterial resulta idónea para el diagnóstico y clasificación de Hipertensión Arterial?

Por:  Nurys B. Armas Rojas, Alfredo Dueñas Herrera, Reinaldo de la Noval García, Magda Acosta González, Carlos A. Yong Medina y  Thais García Rodríguez.  Revista Cubana de Cardiología y Cirugía Cardiovascular Volumen 19, No 2 (2013).

La HTA es un importante factor de riesgo para las enfermedades cardiovasculares, su prevalencia en Cuba es del 30% en los individuos de 15 años y más1. El diagnóstico depende de las cifras de presión arterial (PA) obtenidas del paciente utilizando la medición convencional o método clíni-co (medición de presión arterial, por el médico en el consultorio, utilizando un esfigmomanómetro aneroide o de mercurio, casi siempre en una sola ocasión), sin embargo su uso resulta controversial, por lo cual actualmente se viene recomendado el uso de múltiples mediciones automatizadas para minimizar los errores que ocasiona .